Approval · Notice of Compliance 28713 · 2022
MICRO MN: Notice of Compliance 28713
Issued August 2, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28713
- Date
- August 2, 2022
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Package Insert to reflect a safety update made to the Product Monograph (PM).
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MICRO MN | Not yet assigned | — |
Medicinal ingredients
- MANGANESE SULFATE 0.1 MG per ML